Study Stopped
Stopped due to COVID-19 pandemic
Evaluation of Bowel Cleansing Using the Pure-Vu System in Patients With History of Inadequate Bowel Preparation
1 other identifier
interventional
3
1 country
1
Brief Summary
The study aim to evaluate the performance of Pure-Vu System in cleansing patients' colon with history of inadequate bowel preparation who are indicated for a colonoscopy procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 18, 2019
CompletedFirst Posted
Study publicly available on registry
April 22, 2019
CompletedStudy Start
First participant enrolled
January 21, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 25, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 2, 2021
CompletedFebruary 25, 2021
February 1, 2021
1 month
April 18, 2019
February 23, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Number of Participants With Boston Bowel Preparation Scale( BBPS) >1 in All Colon Segments After the Use of Pure-Vu System
The rating of the cleansing quality was evaluated by using the Boston Bowel Preparation Scale (BBPS), Segment score of 0-3 given to each of the 3 segments of the colon (Left side, Transverse and right side): Score 0- Unprepared colon segment with mucosa not seen due to solid stool that cannot be cleared. Score 1- A portion of the mucosa of the colon segment is seen, but other areas of the colon segment are not seen well due to staining, residual stool, and/or opaque liquid. Score 2- A minor amount of residual staining, small fragments of stool, and/or opaque liquid are visible, but the mucosa of the colon segment are seen well. Score 3-The entire mucosa of the colon segment is seen well with no residual staining, small fragments of stool, or opaque liquid. subject consider as having adequate cleaning if BBPS\>1 in all colon segments
Up to 2 hours
Study Arms (1)
Motus Pure-Vu System
EXPERIMENTALThe Pure-Vu System enables colon cleansing during standard colonoscopy using a standard colonoscope. The cleansing device, which is attached to the tip of the colonoscope and is connected to an external workstation, generates fluid jets within the colon thus dissolving the feces into small parts. The fecal matter \& fluids are drained through the evacuation pipe of the cleansing device into a collecting reservoir.
Interventions
Pure-Vu System is intended to connect to standard colonoscopes to help facilitate intra-procedural cleaning of a poorly prepared colon by irrigating and/or cleaning the colon and evacuating the irrigation fluid (saline water), feces and other bodily fluids and matter, e.g. blood.
Eligibility Criteria
You may qualify if:
- Subjects with history of inadequate bowel preparation.
- Subjects in the age range of 22-75 years inclusive
- Subjects with BodyMass Index (BMI) within the range of 18.5-35 inclusive
- Subject has signed the informed consent
You may not qualify if:
- Patients with active Inflammatory Bowel Disease
- Patients with previous history of acute diverticulitis disease or with prior incomplete colonoscopy due to diverticular disease
- Patients with known bowel obstruction / strictures
- History of prior surgery to colon and/or rectum
- ASA ≥ III
- Renal insufficiency (Creatinine ≥ 1.5mg /dL) (based on medical history)
- Abnormal Liver enzymes (ALT/AST ≥ 2 times upper limits of normal) (based on medical history)
- Patients taking anticoagulants drugs (excluding aspirin) or dual antiplatelet therapy
- Patients with known coagulation disorder (INR \>1.5).
- Patients at risk of hypokalemia or hyponatremia
- Patients with congestive cardiac failure
- Pregnancy (as stated by patient) or breast feeding
- Patients with altered mental status/inability to provide informed consent
- Patients who have participated in another interventional clinical study in the last 2 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chaim Sheba Medical Center
Tel Litwinsky, 5265601, Israel
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 18, 2019
First Posted
April 22, 2019
Study Start
January 21, 2020
Primary Completion
February 25, 2020
Study Completion
February 2, 2021
Last Updated
February 25, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share